Younger age, poverty, recent drug use, depression, and unmet need for ancillary services were linked to lowered antiretroviral therapy (ART) adherence among HIV-positive Hispanic and Latino men who have sex with men (MSM).
Younger age, poverty, recent drug use, depression, and unmet need for ancillary services were linked to lowered antiretroviral therapy (ART) adherence among HIV-positive Hispanic and Latino men who have sex with men (MSM), according to the CDC’s most recent Morbidity and Mortality Weekly Report.
The report also shows that most (63.9%) study participants had multiple reasons for missing at least 1 ART dose.
“Barriers to ART adherence among Hispanic/Latino MSM have been explored in limited contexts; however, nationally representative analyses are lacking,” the study authors pointed out.
Their findings were produced following an analysis of 2015-2019 data from the Medical Monitoring Project on 1673 Hispanic/Latino MSM, which used a 2-stage sampling method for 16 states and 1 territory followed by a random sampling of HIV-positive adults, via in-person or telephone interviews, in National HIV Surveillance System jurisdictions. All of the men self-identified as Hispanic or Latino and MSM and were currently on ART.
Overall, 57.4% (95% CI, 54.7%-60.1%) of the men self-reported that they took ART (ie, did not miss a dose), 52.9% said they had excellent adherence (95% CI, 49.9%-55.9%), and 69.2% said they always took their medication as recommended (95% CI, 66.4%-72.0%), in the previous 30 days.
However, ART adherence was shown to be lower among those who reported the following compared with those who did not:
For this study, ancillary services comprised mental health and substance use disorder counseling, financial support, and food and housing assistance.
The most common reason for missing at least 1 ART dose was forgetting to take medication (63.1%), followed by change in routine/travel (42.3%) and falling asleep early/oversleeping (33.6%). Most (64%) had more than 1 reason for forgetting a dose.
An ART adherence score of 100 indicated perfect ART adherence. For this study, scores were classified as < 85 and ≥ 85. Most (77.3%) of the men had a score of ≥ 85, and in this group sustained viral suppression was more common: 75.3% vs 59.7% (prevalence ratio, 0.61; 95% CI, 0.51-0.74) with lower scores. However, compared with those living above the federal poverty level, fewer of the men living at or below that threshold had an ART adherence score of ≥ 85: 79.7% (95% CI, 78.8%-82.6%) vs 71.5% (95% CI, 66.8%-76.2%).
Most of the study participants were 49 years or younger, had been living with HIV for at least 10 years, attended Ryan White–funded facilities for usual HIV care, had been retained in HIV for the past year, and had public insurance only.
“This report highlights barriers to ART adherence faced by Hispanic/Latino MSM with diagnosed HIV infection,” the report concluded. “Culturally tailored interventions aimed at improving adherence, particularly among Hispanic/Latino MSM who are younger, live in poverty, use drugs, and have unmet needs for ancillary services, might improve viral suppression, leading to better health outcomes and decreasing HIV transmission.”
The report noted 3 important limitations to generalization of its findings:
To improve ART adherence among Hispanic and Latino MSM and to encourage retention and engagement in care, the authors believe that interventions should support these goals, facilitate access to ancillary services, include ancillary services as part out outpatient HIV care, and include reminders to take their ART.
Reference
Crim SM, Tie Y, Beer L, Weiser J, Dasgupta S. Barriers to antiretroviral therapy adherence among HIV-positive Hispanic and Latino men who have sex with men — United States, 2015–2019. MMWR Morb Mortal Wkly Rep. 2020;69(40):1437-1442. doi:10.15585/mmwr.mm6940a1
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More